BOI:EPA
Boiron
25,60 €
arrow_downward
-2,29%(-0,60) 1 d.
3. 9., 17:35:08 GMT+2 · EUR
search
Všetky symboly
1 d.
5 d.
1 m.
6 m.
Od zač. roka do dnes
1 r.
5 r.
MAX.
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre BOI…
Otvoriť
25,80 €
Vysoká
25,90 €
Nízka
25,40 €
Trh. kap.
449,16 mil.
Priem. obj.
2,11 tis.
Objem
2,66 tis.
Pomer cena/zárobky
13,62
Max. za 52 týž.
32,25 €
Min. za 52 týž.
21,45 €
Výnosy na akciu
1,88 €
Akcie v obehu
17,55 mil.
Počet zamestnancov
2 tis.
Otvoriť
25,80 €
Vysoká
25,90 €
Nízka
25,40 €
Trh. kap.
449,16 mil.
Priem. obj.
2,11 tis.
Objem
2,66 tis.
Pomer cena/zárobky
13,62
Max. za 52 týž.
32,25 €
Min. za 52 týž.
21,45 €
Výnosy na akciu
1,88 €
Akcie v obehu
17,55 mil.
Počet zamestnancov
2 tis.
Profil
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
Informácie o subjekte Boiron